These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35188525)

  • 1. Reporting Device-Associated Death Events to the FDA.
    Ryan M; Myers AM; Yustein AS
    JAMA Intern Med; 2022 Apr; 182(4):462. PubMed ID: 35188525
    [No Abstract]   [Full Text] [Related]  

  • 2. Reporting Device-Associated Death Events to the FDA-Reply.
    Lalani C; Kinard M; Redberg RF
    JAMA Intern Med; 2022 Apr; 182(4):462-463. PubMed ID: 35188530
    [No Abstract]   [Full Text] [Related]  

  • 3. Why the FDA can't protect the public.
    Lenzer J; Brownlee S
    BMJ; 2010 Nov; 341():c4753. PubMed ID: 21045048
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications.
    Tau N; Shepshelovich D
    JAMA Intern Med; 2020 Nov; 180(11):1420-1426. PubMed ID: 32986074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA issues final medical device reporting regulation.
    Healthc Hazard Mater Manage; 1996 Feb; 9(5):5-6. PubMed ID: 10154800
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical device recall authority--FDA. Final rule.
    Fed Regist; 1996 Nov; 61(225):59004-22. PubMed ID: 10163116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
    Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmarketing surveillance of medical devices--filling in the gaps.
    Resnic FS; Normand SL
    N Engl J Med; 2012 Mar; 366(10):875-7. PubMed ID: 22332950
    [No Abstract]   [Full Text] [Related]  

  • 12. The Feds do it again. The EMS community grows wary--and weary--of FDA intervention.
    Nordberg M
    Emerg Med Serv; 1995 Mar; 24(3):40-52. PubMed ID: 10140757
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical device vigilance at FDA.
    Gross TP; Kessler LG
    Stud Health Technol Inform; 1996; 28():17-24. PubMed ID: 10164091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warning! AbTox sterilizers recalled--FDA is on the case.
    Blyth PL
    Mater Manag Health Care; 1998 Jun; 7(6):16. PubMed ID: 10183406
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical device reporting: issues with Class III medical devices.
    Zigler J; Walsh J; Zigler J
    Food Drug Law J; 2007; 62(3):573-80. PubMed ID: 17915398
    [No Abstract]   [Full Text] [Related]  

  • 17. Myths and realities in medical packaging.
    Pilchik R
    Med Device Technol; 2003 Mar; 14(2):16-7. PubMed ID: 12698692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting and notification of adverse events in orthopaedics.
    Mihalko WM; Greenwald AS; Lemons J; Kirkpatrick J
    J Am Acad Orthop Surg; 2010 Apr; 18(4):193-8. PubMed ID: 20357228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FDA and the medical device approval process.
    Guez G; Garg A
    Dent Implantol Update; 2012 May; 23(5):33-7. PubMed ID: 22594003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.